Follow
Maryam Nazari
Maryam Nazari
University of Minnesota, Department of Medicinal Chemistry
Verified email at umn.edu
Title
Cited by
Cited by
Year
Is there any potential management against COVID-19? A systematic review and meta-analysis
H Talaie, SM Hosseini, M Nazari, Y Fakhri, A Mousavizadeh, H Vatanpour, ...
DARU Journal of Pharmaceutical Sciences 28, 765-777, 2020
212020
An Updated Review on Drug-Induced Esophagitis and A Helpful Management for Healthcare Providers
S Abdi, F Masboogh, M Nazari, M Abbasinazari
Gastroenterology and Hepatology from Bed to Bench, 2022
142022
Novel 1, 2, 4-oxadiazole derivatives as selective butyrylcholinesterase inhibitors: Design, synthesis and biological evaluation
M Nazari, E Rezaee, R Hariri, T Akbarzadeh, SA Tabatabai
EXCLI journal 20, 907, 2021
132021
Design, synthesis, and preliminary pharmacological evaluation of novel thiazolidinone derivatives as potential benzodiazepine agonists
A Almasirad, M Ghadimi, S Mirahmadi, P Ahmadian Kodakan, R Jahani, ...
Molecular Diversity, 1-12, 2021
122021
Targeting EGFR tyrosine kinase: design, synthesis and biological evaluation of novel quinazolinone derivatives
M Nematpour, E Rezaee, M Nazari, O Hosseini, SA Tabatabai
Iranian journal of pharmaceutical research: IJPR 21 (1), 2022
102022
Novel amide derivatives of 3-phenylglutaric acid as potent soluble epoxide hydrolase inhibitors
E Rezaee, SM Amrolah, M Nazari, SA Tabatabai
Molecular Diversity 25, 45-53, 2021
102021
2D & 3D-QSAR study on novel piperidine and piperazine derivatives as acetylcholinesterase enzyme inhibitors
M Nazari, SA Tabatabai, E Rezaee
Current Computer-Aided Drug Design 14 (4), 391-397, 2018
92018
Quantitative structure activity relationships study of soluble epoxide hydrolase inhibitors using MLR, ANN, CoMFA and CoMSIA methods
M Nazari, SA Tabatabai, E Rezaee
ChemistrySelect 4 (20), 6348-6353, 2019
72019
A Comprehensive Review of Soluble Epoxide Hyådrolase Inhibitors Evaluating their Structure-Activity Relationship
M Nazari, E Rezaee, SA Tabatabai
Mini Reviews in Medicinal Chemistry 23 (1), 99-117, 2023
42023
Synthesis of 4, 6-diphenylpyrimidin-2-ol derivatives as new benzodiazepine receptor ligands
M Khoramjouy, E Rezaee, A Khoshnevis, M Nazari, M Nematpour, ...
Bioorganic Chemistry 109, 104737, 2021
42021
Design, synthesis, and biological evaluation of some 1, 2, 3-triazole derivatives as novel amide-based inhibitors of soluble epoxide hydrolase
E Rezaee, HR Shadzad, M Nazari, SA Tabatabai
Medicinal Chemistry Research 30, 1738-1746, 2021
32021
Risk factors of hospital-acquired thrombocytopenia in toxicological intensive care unit
H Talaie, SM Hosseini, M Nazari, MS Esfahani, B Barari
International Journal of Medical Toxicology and Forensic Medicine 10 (3 …, 2020
32020
Novel medicinal and synthetic chemistry strategies against antimicrobial resistance
E Rezaee, M Nazari, M Mosayebnia, MA Movahed
Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat …, 2022
12022
Bidirectional association between COVID-19 and mental health disorders: A narrative review
H Talaie, SM Hosseini, M Nazari, F Nazemi
International Journal of Medical Toxicology and Forensic Medicine 11 (3), 34101, 2021
12021
The impact of current COVID-19 therapeutics on patients’ clinical improvements based on disease severity; A systematic review
H Talaie, M Nazari, SM Hosseini, A Mousavizadeh, I Alavi-Darazam, ...
Int Pharm Acta 3 (1), e10, 2020
12020
A new route for the synthesis of functionalized benzothiadiazine 1,1-dioxide derivatives via intramolecular C–H activation reactions of N,N′,N′′-trisubstituted …
M Nazari, M Nematpour, E Rezaee, M Jahani, SA Tabatabai
Journal of Sulfur Chemistry 39 (6), 646-655, 2018
12018
Synthesis, Docking Study and Biological Evaluation of Amide‐Based Soluble Epoxide Hydrolase Inhibitors with Novel Secondary Pharmacophore of Pyrimidin‐2‐ol
L Hejazi, A Ebadi, Z Fakhar, M Nazari, E Rezaee, S Abbas Tabatabai
Chemistry & Biodiversity 19 (11), e202200231, 2022
2022
A Survey of the Protective Effect of Vitamin B6 on Linezolid-Associated Hematological Dyscrasia
H Talaie, M Nazari, M Salavati-esfahani, SM Hosseini, B Barari
Iranian Journal of Pharmaceutical Sciences, 1-10, 2021
2021
Design, synthesis and biological evaluation of new 2, 5-diaryl-1, 3, 4-oxadiazole derivatives as selective cyclooxygenase-2 inhibitors
T Vahedpour, E Rezaee, SA Tabatabai, M Nazari
International Pharmacy Acta 4 (1), 4e3: 1-6, 2021
2021
Unexpected Treatment in a Severe Covid-19 Patient with Essential Thrombocythemia Who Received Oseltamivir and Hydroxychloroquine
H Talaie, M Nazari, SM Hosseini, H Ghanean
International Pharmacy Acta 3 (1), 3e7: 1-4, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20